Characterisation of 2-HP-β-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles

References

• Mo Z, Ban J, Zhang Y. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone. Nanomedicine-UK. 2018; 13(11):1239–1253.
   PubMed Web of Science ®Google Scholar
• Ban J, Zhang Y, et al. Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone. Int J Nanomedicine. 2017;12:1329–1339.
   PubMed Web of Science ®Google Scholar
• Tavazzi S, Rossi A, Picarazzi S, et al. Polymer-interaction driven diffusion of eye shadow in soft contact lenses. Cont Lens Anterior Eye. 2017;40(5):335–339.
   PubMed Web of Science ®Google Scholar
• Upendra N. Recent advances in ocular drug delivery system. J Adv Pharm Technol Res. 2014;5(4):151.
   PubMedGoogle Scholar
• Tg DSM, Alf DAC, Centelhas AC, et al. Use of biodegradable collagen-glycosaminoglycan copolymer matrix implant to reduce postoperative fibrosis in strabismus surgery. Taiwan J Ophthalmol. 2017;7(4):227–229.
   PubMedGoogle Scholar
• Almeida H, Lobã OP, et al. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen. Pharm Dev Technol. 2017;22(3):336–349.
   PubMed Web of Science ®Google Scholar
• Imperiale JC, Acosta GB, Sosnik A. Polymer-based carriers for ophthalmic drug delivery. J Control Release. 2018;285:106.
   PubMed Web of Science ®Google Scholar
• Silva-Abreu M, Calpena AC, et al. Optimization, biopharmaceutical profile and therapeutic efficacy of pioglitazone-loaded PLGA-PEG nanospheres as a novel strategy for ocular inflammatory disorders. Pharm Res. 2018;35(1):11.
   PubMed Web of Science ®Google Scholar
• Kalam MA, Alshamsan A. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes. Biomed Pharmacother. 2017;94:402–411.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, et al. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine-UK. 2010;6(2):324–333.
   PubMed Web of Science ®Google Scholar
• Varshochian R, Riazi-Esfahani M, et al. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res.. 2015;103(10):3148–3156.
   Web of Science ®Google Scholar
• Salama HA, Ghorab M, Mahmoud AA, et al. PLGA nanoparticles as subconjunctival injection for management of glaucoma. AAPS Pharmscitech. 2017;18(7):2517–2512.
   PubMed Web of Science ®Google Scholar
• Aachmann FL, Otzen DE, Larsen KL, et al. Structural background of cyclodextrin-protein interactions. Protein Eng Design Select. 2003;16(12):905–912.
   Web of Science ®Google Scholar
• Vega E, Egea MA, Calpena AC, et al. Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA–PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery. 2012;7:1357–1371.
   Google Scholar
• Hayiyana Z, Choonara YE, Makgotloe A, et al. Ester-based hydrophilic cyclodextrin nanosponges for topical ocular drug delivery. Curr Pharm Design. 2016;22(46):6988–6997.
   PubMed Web of Science ®Google Scholar
• Lutfi G, Muzeyyen D. Preparation and characterization of polymeric and lipid nanoparticles of pilocarpine HCl for ocular application. Pharm Dev Technol. 2013;18(3):701–709.
   PubMed Web of Science ®Google Scholar
• Huang X. Preparation and preliminary study of targeting of cyclodextrin coated PLGA nanoparticles [master’s thesis]. Guangzhou: Guangdong Pharmaceutical University; 2018.
   Google Scholar
• Varnell DF, Coleman MM. FT i.r. studies of polymer blends: V. Further observations on polyester-poly(vinyl chloride) blends. Polymer. 1981;22(10):1324–1328.
   Web of Science ®Google Scholar
• Varnell DF, Moskala EJ, Painter PC, et al. On the application of fourier transform infrared spectroscopy to the elucidation of specific interactions in miscible polyester‐poly(vinyl chloride) blends. Polym Eng Sci. 2010;23(12):658–662.
   Web of Science ®Google Scholar
• Pani NR, Nath LK, Acharya S, et al. Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients. J Therm Anal Calorim. 2012;108(1):219–226.
   Web of Science ®Google Scholar
• Deepthi S, Jose J. Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis. Int Ophthalmol. 2018;39(6):1355–1366.
   PubMed Web of Science ®Google Scholar
• Macri A, Marini V, Sangalli G, et al. An artificial aqueous humor as a standard matrix to assess drug concentration in the anterior chamber by high performance liquid chromatography methods. Clin Lab. 2015;61(1–2):47–52.
   PubMed Web of Science ®Google Scholar
• Paolo M, Simone E, et al. Trans-scleral diffusion of triamcinolone acetonide. Curr Eye Res. 2005;30(5):355–361.
   PubMed Web of Science ®Google Scholar
• Malhotra M, Majumdar DK. In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops. Indian J Exp Biol. 1997;35(9):941–947.
   PubMedGoogle Scholar
• Wilhelmus KR. The Draize eye test. Surv ophthalmol. 2001;45(6):493–515.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Pierscionek B, Carew M, et al. Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals. Brit Med Bull. 2015;113(1):59–71.
   PubMed Web of Science ®Google Scholar
• Wolfe GW. Preclinical safety study design templates and estimated costs. Hoboken, NJ: John Wiley & Sons, Inc., 2010.
   Google Scholar
• L Nnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Phys. 1987;253(1):228–231.
   Google Scholar
• Bikiaris D, Papageorgiou GZ, et al. Physicochemical studies on solid dispersions of poorly water-soluble drugs. Thermochim Acta. 2005;439(1-2):58–67.
   Web of Science ®Google Scholar
• Kaushal AM, Gupta P, Bansal AK. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug. 2004;21(3):133.
   PubMedGoogle Scholar
• Gupta P, Bansal AK. Devitrification of amorphous celecoxib. AAPS Pharmscitech. 2005;6(2):E223–E230.
   PubMed Web of Science ®Google Scholar
• Ahuja M, Dhake AS, Sharma SK, et al. Topical ocular delivery of NSAIDs. AAPS J. 2008;10(2):229–241.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Aller M, Guinchard S, et al. New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance. Eur J Pharm Biopharm. 2015;95:203–214.
   PubMed Web of Science ®Google Scholar
• Bozkir A, Denli ZF, Basaran B. Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery. Acta Pol Pharm. 2012;69(4):719–724.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefánsson E. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye. Int J Pharmaceut. 2017;531(2):413–423.
   PubMed Web of Science ®Google Scholar
• Rittenhouse KD, Pollack GM. Microdialysis and drug delivery to the eye. Adv Drug Deliver Rev. 2000;45(2–3):229–241.
   PubMed Web of Science ®Google Scholar
• Ha H, Kim JW, Lee M, et al. Cellular uptake and cytotoxicity of β-lactoglobulin nanoparticles: the effects of particle size and surface charge. Asian-Australas J Anim Sci. 2015;28(3):420–427.
   PubMed Web of Science ®Google Scholar
• Sah AK, Suresh PK. Recent advances in ocular drug delivery, with special emphasis on lipid based nanocarriers. Recent Pat Nanotechnol. 2015;9(2):94–105.
   PubMed Web of Science ®Google Scholar
• Mogi T, Ohtake N, et al. Sustained release of 17β-estradiol from poly (lactide- co -glycolide) microspheres in vitro and in vivo. Coll Surf B Biointerf. 2000;17(3):153–165.
   Web of Science ®Google Scholar
• Meng J, Sturgis TF, Youan B-BC. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci. 2011;44(1–2):57–67.
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, et al. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012;47(1):6–15.
   PubMed Web of Science ®Google Scholar
• Amidi M, Romeijn SG, Borchard G, et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release. 2006;111(1–2):107–116.
   PubMed Web of Science ®Google Scholar
• Makino K, Mogi T, et al. Pulsatile drug release from poly (lactide-co-glycolide) microspheres: how does the composition of the polymer matrices affect the time interval between the initial burst and the pulsatile release of drugs?. Coll Surf B Biointerf. 2000;19(2):173–179.
   Web of Science ®Google Scholar
• Villar-López ME, Nieto-Reyes L, Anguiano-Igea S, et al. Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int J Pharm. 1999;179(2):229–235.
   PubMed Web of Science ®Google Scholar
• Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. The Netherlands: Elsevier B.V; 2000. p. 1–11.
   Google Scholar
• Gã Rsoy A, Tã Rkoä Lu M, Senyã Cel B, et al. Evaluation of tableted microspheres of dipyridamole. Drug Dev Commun. 1995;21(4):503–507.
   Google Scholar